CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
Volume 33, Issue 02, Pages 199-205
Publisher
Cambridge University Press (CUP)
Online
2017-07-13
DOI
10.1017/s0266462317000332
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
- (2016) P. F. Ferrucci et al. ANNALS OF ONCOLOGY
- Actual costs of cancer drugs in 15 European countries
- (2016) Wim H van Harten et al. LANCET ONCOLOGY
- Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab
- (2016) V. Damuzzo et al. OncoImmunology
- Prognostic score for patients with advanced melanoma treated with ipilimumab
- (2015) Stefan Diem et al. EUROPEAN JOURNAL OF CANCER
- Alternative Pricing Strategies for Cancer Drugs
- (2015) Andrea Messori et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness and Cost Effectiveness of Bevacizumab in Metastatic Colorectal Cancer
- (2015) Andrea Messori et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab in the real world
- (2015) Saif S. Ahmad et al. MELANOMA RESEARCH
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- A preliminary analysis of the reduction of chemotherapy waste in the treatment of cancer with centralization of drug preparation
- (2015) Adriano Hyeda et al. Revista da Associacao Medica Brasileira
- Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”: A Novel Measure for Cost-Containment of Drug Expenditure
- (2015) Andrea Navarria et al. VALUE IN HEALTH
- Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
- (2015) Sara Valpione et al. PLoS One
- Drug waste minimization as an effective strategy of cost-containment in Oncology
- (2014) Gianpiero Fasola et al. BMC HEALTH SERVICES RESEARCH
- Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
- (2013) J. Delyon et al. ANNALS OF ONCOLOGY
- Efficacy and Safety of Retreatment with Ipilimumab in Patients with Pretreated Advanced Melanoma Who Progressed after Initially Achieving Disease Control
- (2013) C. Robert et al. CLINICAL CANCER RESEARCH
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started